12 research outputs found
Diabetes Atorvastatin Lipid intervention (DALI) Study Group. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides
No full textDiabetes Atorvastatin Lipid intervention (DALI) Study Group. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides
No full textAtorvastatin, diabetic dyslipidemia, and cognitive functioning.
No full textItem does not contain fulltex
Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes: A potential mechanism to lower plasma triglycerides
No full textAtorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: Effect of sex and the LIPC promoter variant
No full textDo Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
No full text
